These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2175308)

  • 1. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
    Koe BK
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of sertraline: a review.
    Heym J; Koe BK
    J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline: a new antidepressant.
    Doogan DP; Caillard V
    J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical overview of serotonin reuptake inhibitors.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.
    de Montigny C; Chaput Y; Blier P
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():4-8. PubMed ID: 2175309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
    Sprouse J; Clarke T; Reynolds L; Heym J; Rollema H
    Neuropsychopharmacology; 1996 Apr; 14(4):225-31. PubMed ID: 8924190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simulation of latent inhibition in rats by activation of the central serotoninergic system].
    Loskutova LV; Luk'ianenko FIa; Il'iuchenok RIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(6):1157-9. PubMed ID: 2629405
    [No Abstract]   [Full Text] [Related]  

  • 10. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
    Guy S; Silke B
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():37-9. PubMed ID: 2258381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in antidepressant therapy: a review of sertraline, a unique serotonin reuptake inhibitor.
    Cole JO
    J Clin Psychiatry; 1992 Sep; 53(9):333-40. PubMed ID: 1387636
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of serotoninergic agents on downregulation of beta-adrenoceptors by the selective serotonin reuptake inhibitor sertraline.
    Koe BK; Lebel LA
    Arch Int Pharmacodyn Ther; 1995; 329(2):231-44. PubMed ID: 8540763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
    Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
    Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
    J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline: a new specific serotonin reuptake blocker.
    Guthrie SK
    DICP; 1991 Sep; 25(9):952-61. PubMed ID: 1949975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sertraline on psychomotor performance in elderly volunteers.
    Hindmarch I; Shillingford J; Shillingford C
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():34-6. PubMed ID: 2258380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacologic profile of mirtazapine.
    de Boer T
    J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.
    Gill K; Amit Z; Koe BK
    Alcohol; 1988; 5(5):349-54. PubMed ID: 3219181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response?
    Myers RD; Quarfordt SD
    Pharmacol Biochem Behav; 1991 Dec; 40(4):923-8. PubMed ID: 1816578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
    Butler J; Tannian M; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):585-94. PubMed ID: 3222448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.